Accelerate Diagnostics Inc

NASDAQ:AXDX   3:59:50 PM EDT
4.09
+0.06 (+1.36%)
Other Pre-Announcement

Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results

Published: 01/13/2022 14:45 GMT
Accelerate Diagnostics Inc (AXDX) - Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-year 2021 Financial Results.
Sees Q4 Revenue About $3.3 Million.
Sees FY Revenue $11.8 Million.
Gross Margin is Expected to Be Roughly 35% for Full-year 2021.
Accelerate Diagnostics - Net Cash Used is Expected to Be About $47 Million for FY 2021, Resulting in Cash on Hand of $64 Million.
Q4 Revenue View $3.9 Million -- Refinitiv Ibes Data (analyst estimates).
FY2021 Revenue View $12.3 Million -- Refinitiv Ibes Data (analyst estimates).